2,740
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status

, , , , , , , , , , & show all
Article: 2204746 | Received 19 Oct 2022, Accepted 16 Apr 2023, Published online: 12 May 2023